4
Changes in Ownership
Edwards Lifesciences Corp Filed Acc 0001225208-26-004249
CVP,Strategy/Corp Development sold 22,680 shares at an average $80.16 ($1,818,055)
- CVP,Strategy/Corp Development acquired 22,680 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
BOBO DONALD E JR · CVP,Strategy/Corp Development
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-04-02 | Exercise or conversion : show line 1 in the form 10b5-1 | +22,680 | $59.26 | $1,343,942 | 43,946.25 | D |
| 2026-04-02 | Sale : show line 2 in the form 10b5-1 | −4,676 | $80.59 | $376,846 | 39,270.25 | D |
| 2026-04-02 | Sale : show line 3 in the form 10b5-1 | −18,004 | $80.05 | $1,441,209 | 21,266.25 | D |
| Open-market sales · 22,680 sh · avg $80.16 · $1,818,055 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-04-02 | Exercise or conversion : show line 4 in the form 10b5-1 Employee Stock Option (Right to Acquire) | −22,680 | 0 | D |
Loading xslF345X06/doc4.xml…